UnitedHealth Group (NYSE:UNH) Shares Down 1.1% – Time to Sell?

UnitedHealth Group Incorporated (NYSE:UNH) shares were down 1.1% during mid-day trading on Friday . The company traded as low as $275.00 and last traded at $277.3180. Approximately 38,787,962 shares changed hands during trading, an increase of 288% from the average daily volume of 9,996,963 shares. The stock had previously closed at $280.44.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Recent insider and institutional activity has drawn bullish attention — a U.S. senator disclosed a purchase (reported up to $100k), there’s notable call-option activity and some funds have been adding positions, which market participants read as a vote of confidence and potential catalyst for a rebound. QuiverQuant: Senator Purchase & Market Reaction
• Positive Sentiment: Wall Street sentiment remains largely favorable: multiple recent buy/overweight/outperform ratings and a median analyst price target materially above current levels support longer-term upside expectations. (See analyst list and targets in QuiverQuant coverage.) QuiverQuant: Analyst Ratings & Price Targets
• Neutral Sentiment: Zacks Research nudged its Q4 2027 EPS estimate down very slightly (from $3.92 to $3.91). The revision is minimal and does not materially change full-year consensus, but it feeds into near-term headline risk. Zacks: Estimate Revision & Market Note
• Negative Sentiment: Regulatory and reputational concerns persist: social debate about CEO compensation amid claim-denial criticism and an ongoing DOJ probe into Medicare Advantage reimbursements continue to weigh on sentiment and create headline risk. This background tempers enthusiasm from insider buying and analyst optimism. QuiverQuant: Regulatory / DOJ Concerns
• Negative Sentiment: Market reaction: several outlets reported a modest pullback in the stock on recent sessions, reflecting the mix of minor estimate downgrades, headline/regulatory anxiety and profit-taking after prior gains. Short-term technicals and lower session closes are being highlighted by the press. Yahoo Finance: Recent Session Drop Zacks: Market Dip Coverage MSN: Stock Move Report

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research note on Friday, January 23rd. Jefferies Financial Group lowered their price target on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Truist Financial dropped their price target on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Finally, Weiss Ratings cut shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Stock Performance

The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The stock’s fifty day simple moving average is $298.52 and its 200 day simple moving average is $324.39. The company has a market cap of $251.71 billion, a price-to-earnings ratio of 21.02, a P/E/G ratio of 1.31 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same quarter in the prior year, the firm posted $6.81 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.2%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is currently 67.02%.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP acquired a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Anfield Capital Management LLC grew its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the 4th quarter valued at about $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $27,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.